Literature DB >> 8686917

Isotopic differences in human growth hormone preparations.

F P Abramson, B L Osborn, Y Teffera.   

Abstract

The 13C/12C isotope ratios have been measured for human pituitary growth hormone and three commercial growth hormone products in an attempt to differentiate endogenous versus exogenous origin. This might be a strategy to detect doping, as has recently been recognized for testosterone. While all preparations are statistically different from each other, we find that only Humatrope from Lilly has a carbon isotope ratio that is markedly different from those of human growth hormone or Genentech's Nutropin and Protropin. The low renal clearance of growth hormone reduces the applicability of this concept.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8686917     DOI: 10.1021/ac960064l

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  3 in total

1.  The future of doping control in athletes. Issues related to blood sampling.

Authors:  K I Birkeland; P Hemmersbach
Journal:  Sports Med       Date:  1999-07       Impact factor: 11.136

2.  Problems with GH doping in sports.

Authors:  M Bidlingmaier; Z Wu; C J Strasburger
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

3.  Determination of carbon isotope ratios in amino acids, proteins, and oligosaccharides by inductively coupled plasma-mass spectrometry.

Authors:  Elise T Luong; R S Houk
Journal:  J Am Soc Mass Spectrom       Date:  2003-04       Impact factor: 3.109

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.